Connecta launches phase 2a trial of neuroplasticity modulator

10th June 2026 Uncategorised 0

Study marks major milestone for CTH120 as company advances disease‑modifying ambitions

More: Connecta launches phase 2a trial of neuroplasticity modulator
Source: News